You are viewing: Australia Peritoneal Dialysis Market analysis
Part of: Peritoneal Dialysis Market (Global)

The Australia Peritoneal Dialysis Market was valued at $129.8 Million in 2026 and projected to reach to $175.5 Million by 2031, representing a compound annual growth rate of 6.2%. Australia's peritoneal dialysis market is positioned for steady growth through 2031, driven by demographic shifts and increasing chronic kidney disease incidence among the aging population.

Australia Peritoneal Dialysis Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Australia Peritoneal Dialysis Market Trends and Insights

  • This steady expansion reflects Australia's aging population, rising prevalence of chronic kidney disease, and increasing adoption of home-based dialysis therapies.
  • Australia's advanced healthcare infrastructure and strong reimbursement frameworks support market penetration across both urban and regional centers. The Australian peritoneal dialysis market benefits from favorable demographic trends and clinical preference shifts toward patient-centric treatment modalities.
  • Between 2026 and 2031, Australia is expected to see growing investment in dialysis technology and improved access to peritoneal dialysis training programs.
  • Australia's regulatory environment and quality standards continue to drive innovation and standardization across dialysis service providers, positioning the country as a key market within the Asia Pacific region..

Key Market Statistics

  • CAGR (2026-2031) 6.2% CAGR
  • Market Size, 2026 ~USD 129.8 Million
  • Forecast, 2031 ~USD 175.5 Million
  • Country Australia

Australia Peritoneal Dialysis Market Overview

Market Size & Growth :

Australia's peritoneal dialysis market is valued at USD 129.8 million in 2026, expanding to USD 175.5 million by 2031, with a robust CAGR of 6.2%, outpacing the global average of 6%.

Aging Population Driver :

Australia's rapidly aging demographic is significantly increasing chronic kidney disease prevalence, creating sustained demand for peritoneal dialysis as a preferred renal replacement therapy option.

Home-Based Therapy Adoption :

Growing patient preference for home-based dialysis solutions in Australia is driving market expansion, supported by improved quality of life outcomes and reduced healthcare facility burden.

Advanced Healthcare Infrastructure :

Australia's sophisticated healthcare system, strong regulatory framework, and high adoption of innovative medical technologies create an ideal environment for peritoneal dialysis market growth.

Australia Peritoneal Dialysis Market Dynamics

  • The market benefits from Australia's advanced healthcare infrastructure, strong reimbursement policies, and growing patient awareness of home-based dialysis benefits.
  • Healthcare providers are increasingly recommending peritoneal dialysis as a cost-effective and patient-centric alternative to hemodialysis, supporting market expansion.
  • Technological innovations in dialysis equipment and improved clinical outcomes will further accelerate adoption rates across Australian healthcare facilities and home settings..

Market Ecosystem

logo-mobile

PERITONEAL DIALYSIS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
A global leader in kidney care offering a comprehensive peritoneal dialysis portfolio, including automated peritoneal dialysis (APD) cyclers, PD solutions, consumables, and digital therapy management platforms. The company supports home-based dialysis through extensive training, remote monitoring, and a strong global clinical network across North America, Europe, Asia Pacific, Latin America, and the Middle East. Improves treatment efficiency and patient independence through advanced APD technologies. Enhances therapy adherence, reduces infection risks with standardized protocols, and enables remote patient monitoring for better clinical outcomes and quality of life.
A dedicated kidney care company providing a broad portfolio of APD systems, CAPD solutions, PD cyclers, dialysis solutions, transfer sets, and digital renal care technologies. Vantive focuses on expanding access to home dialysis through connected care platforms, clinician education, and patient support programs across developed and emerging markets. Enables personalized home dialysis, improves treatment continuity, and enhances patient comfort. Connected care solutions support remote monitoring, optimize therapy adherence, and improve long-term clinical outcomes while reducing healthcare resource utilization.
Offers advanced PD access products including catheters, transfer sets, connectors, needles, and infection-prevention technologies used in peritoneal dialysis procedures. The company's products support safe catheter placement and standardized PD practices across hospitals and home-care settings. Minimizes catheter-related complications and peritonitis risk while improving procedural safety and reliability. Supports efficient PD initiation and maintenance, enhancing patient safety and reducing treatment interruptions.
Provides minimally invasive vascular access technologies, guidewires, introducers, catheters, and surgical products that facilitate safe placement and management of peritoneal dialysis catheters. The company leverages advanced medical device expertise to support renal access procedures worldwide. Enhances procedural success, improves catheter placement accuracy, and reduces access-related complications. Reliable device performance supports broader adoption of peritoneal dialysis and improves clinician confidence during implantation procedures.
One of the world's leading dialysis service providers offering comprehensive home-based peritoneal dialysis programs supported by patient education, clinical training, remote monitoring, and integrated kidney care services. DaVita emphasizes value-based care and multidisciplinary care coordination to expand PD adoption. Increases access to home-based dialysis, improves patient engagement and treatment adherence, and supports personalized care pathways. Integrated care models reduce hospitalization rates, improve long-term patient outcomes, and enhance overall healthcare cost efficiency.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Australia's peritoneal dialysis market is valued at USD 129.8 million in 2026 and will reach USD 175.5 million by 2031, growing at 6.2% CAGR.
    • Australia's aging demographic and rising chronic kidney disease prevalence are primary drivers of peritoneal dialysis adoption.
    • Australia's advanced healthcare infrastructure and reimbursement systems support sustained market growth through 2031.
    • Australia's regulatory standards and quality frameworks position it as a leading peritoneal dialysis market in Asia Pacific.

    Peritoneal Dialysis Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment PERITONEAL DIALYSIS MACHINES (Type)
    Forecast Period 2026-2031
    Growth Rate CAGR of 6% from 2026 to 2031
    Largest Segment PRODUCTS (Offering)
    Market Size Base Year (Billions) ~USD 10.58 (2026)
    Revenue Forecast (Billions) ~USD 14.16 (2031)
    Segments Covered Offering, Type, Modality, Disease Indication, End User

    Australia Peritoneal Dialysis Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Offering

    • Products
    • Services

    By Type

    • Other Peritoneal Dialysis Products
    • Peritoneal Dialysis Catheters
    • Peritoneal Dialysis Machines
    • Peritoneal Dialysis Solution Bags
    • Peritoneal Dialysis Transfer Sets

    By Modality

    • Automated Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (Capd)

    By Disease Indication

    • Acute Kidney Injury
    • End-Stage Renal Disease
    • End-Stage Renal Diseases
    • Other Diseases

    By End User

    • Homecare
    • Hospitals & Independent Dialysis Centers
    • Other End Users

    Target Audience

    • Medical Device Manufacturers : Peritoneal dialysis equipment and consumables manufacturers need Australia-specific market data to assess market potential, competitive positioning, and regulatory pathways for product launches.
    • Healthcare Providers & Hospitals : Australian hospitals and dialysis centers require market insights to optimize service offerings, plan capacity expansion, and align peritoneal dialysis programs with growing patient demand.
    • Pharmaceutical Companies : Drug manufacturers developing dialysate solutions and related therapeutics need Australia market intelligence to guide R&D investments and commercialization strategies.
    • Healthcare Investors & PE Firms : Investment professionals evaluating opportunities in Australian renal care require detailed market forecasts, growth drivers, and competitive dynamics to inform investment decisions.
    • Government & Policy Makers : Australian health authorities and policymakers need market data to develop kidney disease management strategies, allocate healthcare resources, and evaluate dialysis therapy coverage policies.

    Reasons to Buy this Report

    • Market-Specific Sizing & Forecasts : Access precise market valuations for Australia (USD 129.8M in 2026, USD 175.5M in 2031) with detailed CAGR analysis to support strategic planning and investment decisions.
    • Demographic & Clinical Insights : Understand Australia's aging population dynamics and rising chronic kidney disease prevalence to identify growth opportunities and target patient segments effectively.
    • Competitive Landscape Analysis : Gain intelligence on key market players, treatment adoption rates, and competitive positioning specific to the Australian peritoneal dialysis market.
    • Regulatory & Reimbursement Framework : Detailed analysis of Australia's healthcare policies, Medicare reimbursement structures, and regulatory requirements affecting peritoneal dialysis market dynamics.
    • Strategic Market Entry Planning : Leverage Australia-specific market data to develop informed go-to-market strategies, partnership opportunities, and expansion plans in the growing home-based dialysis segment.

    Frequently asked questions

    What is the current size of Australia's peritoneal dialysis market?

    Australia's peritoneal dialysis market is estimated at USD 129.8 million in 2026.

    What is the projected market size for Australia's peritoneal dialysis market by 2031?

    Australia's peritoneal dialysis market is projected to reach USD 175.5 million by 2031.

    What is the growth rate of Australia's peritoneal dialysis market?

    Australia's peritoneal dialysis market is expected to grow at a compound annual growth rate of 6.2% between 2026 and 2031.

    What factors are driving growth in Australia's peritoneal dialysis market?

    Key drivers include Australia's aging population, increasing prevalence of chronic kidney disease, preference for home-based dialysis therapies, and strong healthcare infrastructure with favorable reimbursement policies.

    How does Australia's peritoneal dialysis market compare to other Asia Pacific countries?

    Australia's advanced regulatory standards, quality frameworks, and healthcare infrastructure position it as a leading peritoneal dialysis market within the Asia Pacific region.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the peritoneal dialysis market. Exhaustive secondary research was done to collect information on the Peritoneal dialysis market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Peritoneal dialysis market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the Peritoneal dialysis market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/Managing Directors, Marketing Heads/Directors, Sales Directors, Marketing/Sales Managers, Regional/Area Sales Managers, Export/Import Heads/Managers, and Other Peritoneal dialysis Market Related Personnel from various companies and organizations operating in the Peritoneal dialysis market. Primary sources from the demand side included Vice Presidents, C-level Executives, Department Heads, Enterprises, Individuals, Supply Management Team of Hospitals, Clinic Personnel, and Laboratory Technicians.

    Breakdown of Primary Interviews

    Peritoneal Dialysis Market Size, and Share

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
    Note 2: Other primary roles include sales, marketing, and product management.
    Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the Peritoneal dialysis market. These methods were also used extensively to estimate the sizes of various market subsegments. The research methodology used to estimate the market size includes the following:

    Peritoneal Dialysis Market: Top-Down and Bottom-Up Approach

    Peritoneal Dialysis Market Top Down and Bottom Up Approach

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown were used as needed to complete the market engineering process and derive precise statistics for all segments.

    Approach for deriving the market size and estimating market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined through a thorough analysis of their Peritoneal dialysis sales. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Phototherapy involves the utilization of a specific wavelength of light for the treatment of various medical conditions (such as psoriasis, vitiligo, acne vulgaris, neonatal jaundice, cancer, and eczema) through exposure of the affected area of the body to a light source.

    Key Stakeholders

    • Peritoneal dialysis product manufacturers
    • Distributors, channel partners, and third-party suppliers
    • Peritoneal dialysis service providers
    • Dialysis research laboratories
    • Dialysis associations and organizations
    • Healthcare service providers (including hospitals and dialysis centers)
    • Dialysis nurses and nephrologists
    • Academic medical centers and universities
    • Business research and consulting service providers
    • Venture capitalists and other government funding organizations

    Report Objectives

    • To describe, analyze, and forecast the Peritoneal dialysis market, by offerings, modality, disease indication, end user, and region
    • To describe and forecast the Peritoneal dialysis market for key regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
    • To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the Peritoneal dialysis market
    • To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s five forces, and prices pertaining to the market under study
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
    • To profile key players and comprehensively analyze their market shares and core competencies2 in the Peritoneal dialysis market
    • To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the Peritoneal dialysis market

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of each company

    Regional Analysis

    • Further breakdown of the Rest of Asia Pacific Peritoneal dialysis market into Vietnam, New Zealand, and others.
    • Further breakdown of the Rest of Latin America Peritoneal dialysis market into Colombia, Chile, Ecuador, and others.
    • Further breakdown of the Rest of Europe Peritoneal dialysis market into Belgium, Russia, the Netherlands, Switzerland, and others.

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Get the Full Peritoneal Dialysis Market Report

    Full forecast, segment splits, and company analysis for all Peritoneal Dialysis Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status